![Global Rapid Diagnostics Market](https://res.cloudinary.com/devmoveo/image/upload/v1679999153/skyquest/report/phpWkltVW.jpg)
Report ID: SQMIG35A2152
Report ID:
SQMIG35A2152 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
121 |
Figures:
70
Global Rapid Diagnostics Market size was valued at USD 29.26 billion in 2022 and is poised to grow from USD 35.39 billion in 2023 to USD 162.08 billion by 2031, at a CAGR of 20.95% during the forecast period (2024-2031).
Rapid diagnostic tests (RDT) are mostly used in preliminarily or urgently screening for medical issues in medical facilities with limited resources. Point-of-care testing in primary care is made possible by RDTS through simple, rapid operations. Numerous traditional diagnostic procedures, including quick antibody tests (including the rapid HIV test), rapid plasma regain, and rapid antigen tests (including the rapid influenza diagnostic test and the rapid malaria antigen) detection assays, all incorporate rapid diagnostics. Rapid diagnostic tests are widely used for screening, epidemiology, patient management, and diagnosis. Increased demand for quick diagnostic tests in decentralised settings and increased public awareness of the benefits of early diagnosis are the main drivers of market expansion.
Additionally, the market is expected to rise due to the growing demand for accurate diagnostic tests at affordable prices. Quick diagnostics market growth is hampered by consumers' ignorance of newer rapid diagnostic tests that are on the market. In addition, the market for quick diagnostics will benefit from the growing demand for bedside diagnostic testing.
The point of care rapid diagnostics market consists of a variety of testing tools, such as glucose monitoring kits, pregnancy and fertility testing kits, infectious disease testing kits, urinalysis testing kits, haematological testing kits, cardiometabolic monitoring kits, and other similar testing tools. Hospitals, professional clinics, and private residences all employ these kinds of tests. The point of care and rapid diagnostics market Market growth is mainly driven by the high prevalence of infectious diseases, supportive government policies and rising number of CLIA-waived POC tests.
US Rapid Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2152